KRAS and familial pancreatic carcinoma: In fact, a method to detect pancreatic cancer by assessing five DNA methylation markers in cfDNA along with KRAS mutation status had 68% sensitivity and 86% specificity when tested on cfDNA samples from 47 pancreatic cancer patients and 14 normal volunteers [71].